Anthrax: ENT manifestations and current concepts.
In light of recent events, anthrax has once again taken center stage in the world of science and the world in which we live. Because patients with anthrax may initially present to otolaryngology clinics, it is important for the otolaryngologist to know how to diagnose and treat this entity. This article will present current information on epidemiology, microbiology, pathogenesis/clinical manifestations, diagnosis, and treatment with a particular interest in the head and neck region.
Wirtschafter
Ari
A
Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
Cherukuri
Sreekant
S
Benninger
Michael S
MS
D000881:Anthrax / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001408:Bacillus anthracis / Q000302:isolation & purification*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D010608:Pharyngeal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D004318:Doxycycline